Fennec Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Fennec Pharmaceuticals

14/05/2024 15:22

* Fennec Pharmaceuticals Inc  FENC.OQ  reported quarterly
adjusted
earnings of 47 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -23 cents.  The mean expectation of six analysts
for the quarter was for earnings of 26 cents per share. Wall
Street expected results to range from -8 cents to $1.54 per
share.
    * Revenue rose 1,413.2% to $25.38 million from a year ago;
analysts expected $18.88 million. 
    * Fennec Pharmaceuticals Inc's reported EPS for the quarter
was 47
cents​.
    * The company reported quarterly net income of $12.84
million.
    * Fennec Pharmaceuticals Inc shares had fallen by 9.9% this
quarter and lost 10.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4,466.7% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Fennec
Pharmaceuticals Inc is $18.00 
This summary was machine generated from LSEG data May 14 at
02:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.26           0.47           Beat
 Dec. 31 2023      -0.02          -0.10          Missed
 Sep. 30 2023      -0.12          -0.07          Beat
 Jun. 30 2023      -0.16          -0.21          Missed